Literature DB >> 29667881

The ability of ADC measurements in the assessment of patients with stage I endometrial carcinoma based on three risk categories.

Jia Liu1, Feng Yuan1, Shijia Wang1, Xiaojun Chen1, Fenghua Ma1, Guofu Zhang1, Xiaomei Tian1.   

Abstract

BACKGROUND: Better selection of patients with intermediate and high-risk stage I endometrial carcinoma (EC) for lymphadenectomy has an important effect on the prognosis.
PURPOSE: To investigate the role of apparent diffusion coefficient (ADC) measurements in the assessment of stage I EC patients based on three risk categories.
MATERIAL AND METHODS: We retrospectively studied 80 patients with EC and 28 cervical cancer patients with normal endometrium. 1.5-T conventional magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) (b = 0, 1000 s/mm2) were performed, and ADC values were calculated. Sixty-eight stage I EC patients were divided into three groups: low-risk EC (group 1); intermediate-risk EC (group 2); and high-risk EC (group 3). The remaining 12 EC patients were in stages II and III. Intraclass coefficient, Mann-Whitney U test, Kruskal-Wallis test, and receiver operating characteristics were used for statistical analysis.
RESULTS: The mean ADC values ( × 10-3 mm2 /s) were 0.851 ± 0.131, 0.734 ± 0.108, and 0.710 ± 0.108 for groups 1, 2 and 3, respectively. Significant statistical differences were achieved for the three groups ( P = 0.0005). The mean ADC values of group 1 were significantly lower than those in group 2 + 3 (0.725 ± 0.106; P = 0.0001). For the prediction of groups 2 + 3, the area under the curve of 0.786 and the cut-off value of ≤ 0.742 were identified, with a sensitivity, specificity, and accuracy of 66.67%, 84.09%, and 73.53%, respectively.
CONCLUSION: ADC measurements may have the potential to select intermediate-risk and high-risk stage I EC patients for lymphadenectomy.

Entities:  

Keywords:  Endometrial carcinoma; apparent diffusion coefficient; diffusion-weighted imaging; lymphadenectomy; magnetic resonance imaging; risk categorization

Mesh:

Year:  2018        PMID: 29667881     DOI: 10.1177/0284185118768105

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Preoperative MRI and immunohistochemical examination for the prediction of high-risk endometrial cancer.

Authors:  Jingya Chen; Weimin Fan; Hailei Gu; Wei Zhang; Yuting Liu; Yajing Wang; Zhaochun Pan; Zhongqiu Wang
Journal:  Gland Surg       Date:  2021-07

2.  Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer.

Authors:  Jie Zhang; Qingwei Liu; Jie Li; Zhiling Liu; Ximing Wang; Na Li; Zhaoqin Huang; Han Xu
Journal:  BMC Med Imaging       Date:  2022-07-18       Impact factor: 2.795

3.  Pathological characteristics and risk stratification in patients with stage I endometrial cancer: utility of apparent diffusion coefficient histogram analysis.

Authors:  Taein An; Chan Kyo Kim
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

4.  MRI-Based Radiomic Model for Preoperative Risk stratification in Stage I Endometrial Cancer.

Authors:  Jingya Chen; Hailei Gu; Weimin Fan; Yaohui Wang; Shuai Chen; Xiao Chen; Zhongqiu Wang
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

5.  The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients.

Authors:  Quan Quan; Hui Peng; Sainan Gong; Jiali Liu; Yunfeng Lu; Rongsheng Chen; Xiaoling Mu
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.